These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 34718336)

  • 1. Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway.
    Tian W; Yang X; Yang H; Lv M; Sun X; Zhou B
    Cell Death Dis; 2021 Oct; 12(11):1030. PubMed ID: 34718336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblasts secreted miR-103a-3p suppresses apoptosis and promotes cisplatin resistance in non-small cell lung cancer.
    Wang H; Huang H; Wang L; Liu Y; Wang M; Zhao S; Lu G; Kang X
    Aging (Albany NY); 2021 May; 13(10):14456-14468. PubMed ID: 33999859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal miR-3180-3p inhibits proliferation and metastasis of non-small cell lung cancer by downregulating FOXP4.
    Chen T; Liu Y; Chen J; Zheng H; Chen Q; Zhao J
    Thorac Cancer; 2021 Feb; 12(3):372-381. PubMed ID: 33350095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-323-3p Targeting Transmembrane Protein with EGF-Like and 2 Follistatin Domain (TMEFF2) Inhibits Human Lung Cancer A549 Cell Apoptosis by Regulation of AKT and ERK Signaling Pathways.
    Fan JM; Zheng ZR; Zeng YM; Chen XY
    Med Sci Monit; 2020 Feb; 26():e919454. PubMed ID: 32009129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy.
    Ma Y; Yuwen D; Chen J; Zheng B; Gao J; Fan M; Xue W; Wang Y; Li W; Shu Y; Xu Q; Shen Y
    Int J Nanomedicine; 2019; 14():8121-8132. PubMed ID: 31632022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiroRNA-31-3p Promotes the Invasion and Metastasis of Non-Small-Cell Lung Cancer Cells by Targeting Forkhead Box 1 (FOXO1).
    Zeng X; Liu D; Peng G; Liu J; Yang H
    Comput Math Methods Med; 2022; 2022():4597087. PubMed ID: 35126623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated
    Sui J; Zhao Q; Zhang Y; Liang G
    DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
    J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p.
    Wei F; Ma C; Zhou T; Dong X; Luo Q; Geng L; Ding L; Zhang Y; Zhang L; Li N; Li Y; Liu Y
    Mol Cancer; 2017 Jul; 16(1):132. PubMed ID: 28743280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN.
    Ren P; Gong F; Zhang Y; Jiang J; Zhang H
    Tumour Biol; 2016 Mar; 37(3):3215-25. PubMed ID: 26432332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMSCs-Derived Exosomal MiR-126-3p Inhibits the Viability of NSCLC Cells by Targeting PTPN9.
    Chen J; Ding C; Yang X; Zhao J
    J BUON; 2021; 26(5):1832-1841. PubMed ID: 34761590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-29b-3p targetedly regulates VEGF to inhibit tumor progression and cisplatin resistance through Nrf2/HO-1 signaling pathway in non-small cell lung cancer.
    Sun Z; Ren M; Niu J; Tang G; Li Y; Kong F; Song X
    Environ Toxicol; 2024 Jul; 39(7):3956-3966. PubMed ID: 38587027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis.
    Wang A; Wang J
    DNA Cell Biol; 2020 Jul; 39(7):1290-1298. PubMed ID: 32364763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
    Shao N; Song L; Sun X
    Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo.
    Ni L; Xu J; Zhao F; Dai X; Tao J; Pan J; Shi A; Shen Z; Su C; Zhang Y
    Eur J Pharmacol; 2021 May; 899():174054. PubMed ID: 33771522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA LINC00342 regulated cell growth and metastasis in non-small cell lung cancer via targeting miR-203a-3p.
    Chen QF; Kong JL; Zou SC; Gao H; Wang F; Qin SM; Wang W
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7408-7418. PubMed ID: 31539128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulation of Neuropilin 1 expression by miR-338-3p promotes non-small cell lung cancer via changes in EGFR signaling.
    Ding Z; Zhu J; Zeng Y; Du W; Zhang Y; Tang H; Zheng Y; Qin H; Liu Z; Huang JA
    Mol Carcinog; 2019 Jun; 58(6):1019-1032. PubMed ID: 30811684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
    Zhou YL; Xu YJ; Qiao CW
    Int J Clin Exp Pathol; 2015; 8(6):6312-22. PubMed ID: 26261507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.